Liquid biopsy is considered a valid strategy to improve patients’ selection and treatment monitoring in clinical practice. Indeed Circulating Tumor Cells (CTCs) represent an important component of liquid biopsy and their clinical evaluation is becoming fundamental for a better patients’ stratification. Several techniques have been developed for CTCs isolation and enrichment and in this chapter we provide an updated overview of the main strategies that can be used
Circulating tumor cells (CTCs) can be found in the peripheral blood of patients with different solid...
Over the last decade, liquid biopsy has gained much attention as a powerful tool in personalized med...
New sensitive assays are currently available for the detection of circulating tumor DNA (ctDNA) and ...
Liquid biopsy is considered a valid strategy to improve patients’ selection and treatment monitoring...
A few years ago, the analysis of circulating tumor cells (CTCs) in the blood of patients with cancer...
From February 7–11, 2011, the multidisciplinary Lorentz Workshop Circulating Tumor Cell (CTC) Isolat...
International audience"Liquid biopsy" focusing on the analysis of circulating tumor cells (CTC) and ...
International audienceAbstract The long-term effects of cancer on patient quality of life and its ec...
From February 7-11, 2011, the multidisciplinary Lorentz Workshop Circulating Tumor Cell (CTC) Isolat...
International audienceThe selection of circulating tumor cells (CTCs) directly from blood as a real-...
Breast cancer is the most common neoplasm in women worldwide. Tissue biopsy, currently the gold stan...
Circulating tumor cells (CTCs) are cells that are shed from tumors into the bloodstream. Cell enrich...
Circulating tumor cells (CTCs) are very attractive surrogate markers for systemic cancer. Currently,...
Recent technological advances have enabled the detection and detailed characterization of circulatin...
Over the past decade, the detection and analysis of liquid biopsy biomarkers such as circulating tum...
Circulating tumor cells (CTCs) can be found in the peripheral blood of patients with different solid...
Over the last decade, liquid biopsy has gained much attention as a powerful tool in personalized med...
New sensitive assays are currently available for the detection of circulating tumor DNA (ctDNA) and ...
Liquid biopsy is considered a valid strategy to improve patients’ selection and treatment monitoring...
A few years ago, the analysis of circulating tumor cells (CTCs) in the blood of patients with cancer...
From February 7–11, 2011, the multidisciplinary Lorentz Workshop Circulating Tumor Cell (CTC) Isolat...
International audience"Liquid biopsy" focusing on the analysis of circulating tumor cells (CTC) and ...
International audienceAbstract The long-term effects of cancer on patient quality of life and its ec...
From February 7-11, 2011, the multidisciplinary Lorentz Workshop Circulating Tumor Cell (CTC) Isolat...
International audienceThe selection of circulating tumor cells (CTCs) directly from blood as a real-...
Breast cancer is the most common neoplasm in women worldwide. Tissue biopsy, currently the gold stan...
Circulating tumor cells (CTCs) are cells that are shed from tumors into the bloodstream. Cell enrich...
Circulating tumor cells (CTCs) are very attractive surrogate markers for systemic cancer. Currently,...
Recent technological advances have enabled the detection and detailed characterization of circulatin...
Over the past decade, the detection and analysis of liquid biopsy biomarkers such as circulating tum...
Circulating tumor cells (CTCs) can be found in the peripheral blood of patients with different solid...
Over the last decade, liquid biopsy has gained much attention as a powerful tool in personalized med...
New sensitive assays are currently available for the detection of circulating tumor DNA (ctDNA) and ...